Metraipolis › archive › dc_4fac08ddacc3

Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study — Europe PMC PMID:41217768

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41217768
DOI
10.1158/2767-9764.crc-25-0384
License (as archived)
solo-consultazione
Archived
2026-11-08T02:04:19.956Z
SHA-256 of the archived text
fe44d08611557649a2dc1ebe3fe8a916d97d1664a19e57e753a7eca2895a1b09
Stable URL of this page
https://metraipolis.com/documento/dc_4fac08ddacc3

How to cite

Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study — Europe PMC PMID:41217768 — Europe PMC (en), https://europepmc.org/article/MED/41217768 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4fac08ddacc3 (Metraipolis archive dc_4fac08ddacc3, sha256 fe44d08611557649a2dc1ebe3fe8a916d97d1664a19e57e753a7eca2895a1b09)
BibTeX
@misc{dc4fac08ddacc3,
  title = {Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study — Europe PMC PMID:41217768},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41217768},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4fac08ddacc3; sha256 fe44d08611557649a2dc1ebe3fe8a916d97d1664a19e57e753a7eca2895a1b09},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41217768. Agents can read the archived copy with the MCP tool read_document.